2 results
Approved WMOCompleted
To determine the specificity of the effects of histamine H1-receptor blockade on different cognitive functions and processes.
Approved WMOPending
To evaluate the efficacy of lebrikizumab compared with placebo in patients not adequately controlled with cyclosporine or for whom cyclosporine is not medically advisable up to Week 16